Although the meta-analysis and the majority of included studies reported raised CRP in GAD, there was wide variation in reporting and adjustment for important potential moderators, including comorbid MDD, use of medications, assay used and time of day of blood collection, all of which likely contributed to the high degree of heterogeneity between studies. The gene discussed is CRP; the disease is major depressive disorder.